Advertisements
Advertisements
प्रश्न
Consult internet and find out how to make orally active protein pharmaceutical. What is the major problem to be encountered?
उत्तर
Orally active protein pharmaceuticals contain biologically active materials such as peptides or proteins, antibodies, and polymeric beads. It is administrated orally into the body through various formulations. It involves the encapsulation of protein or peptide in liposomes or formulations using penetration enhancers. These proteins or peptides are used for the treatment of various diseases and are also used as vaccines. However, the oral administration of these peptides or proteins has some problems related to it. Once these proteins are ingested, the proteases present in the stomach juices denature the protein. As a result, their effect will be nullified. Hence, it is necessary to protect the therapeutic protein from digestive enzymes, if taken orally. This is the reason for the proteins to be injected directly into the target site.
APPEARS IN
संबंधित प्रश्न
Recombination DNA−technology is of great importance in the field of medicine. With the help of a flow chart, show how this technology has been used in preparing genetically engineered human insulins.
State the cause of ADA deficiency in humans.Mention a possible cure for an ADA deficiency patient.
What is gene therapy? Name the first clinical case in which it was used.
Describe the role of primers.
The first clinical gene therapy was done for the treatment of ________.
ELISA is mainly used for ____________.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
How was Insulin obtained before the advent of rDNA technology? What were the problems encountered?
What are recombinant vaccines? Explain the types.
Human insulin is being commercially produced forma transgenic species of ______.
The site of production of ADA the body is ______.
A pathophysiology is the ______.
When gene targetting involving gene amplification is attempted in an individual’s tissue to treat disease, it is known as ______
Can a disease be detected before its symptoms appear? Explain the principle involved.
Why is it that the line of treatment for a genetic disease is different from infectious diseases?
Who was the first patient who was given gene therapy? Why was the given treatment recurrent in nature?
Taking examples under each category, discuss upstream and downstream processing.
When a foreign DNA is introduced into an organism, how is it maintained in the host and how is it transferred to the progeny of the organism?
Name the five key tools for accomplishing the tasks of recombinant DNA technology. Also mention the functions of each tool.
Eli Lilly's contribution for diabetic patients through r-DNA technology has been overwhelmingly accepted. Explain how?
